JP2013520167A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520167A5
JP2013520167A5 JP2012553903A JP2012553903A JP2013520167A5 JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5 JP 2012553903 A JP2012553903 A JP 2012553903A JP 2012553903 A JP2012553903 A JP 2012553903A JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
immune response
administration
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012553903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/000300 external-priority patent/WO2011102900A1/en
Publication of JP2013520167A publication Critical patent/JP2013520167A/ja
Publication of JP2013520167A5 publication Critical patent/JP2013520167A5/ja
Pending legal-status Critical Current

Links

JP2012553903A 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン Pending JP2013520167A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30576810P 2010-02-18 2010-02-18
US30575910P 2010-02-18 2010-02-18
US61/305,759 2010-02-18
US61/305,768 2010-02-18
PCT/US2011/000300 WO2011102900A1 (en) 2010-02-18 2011-02-18 Universal virus-like particle (vlp) influenza vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016131988A Division JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Publications (2)

Publication Number Publication Date
JP2013520167A JP2013520167A (ja) 2013-06-06
JP2013520167A5 true JP2013520167A5 (enExample) 2014-04-03

Family

ID=44483229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553903A Pending JP2013520167A (ja) 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Country Status (6)

Country Link
US (4) US9352031B2 (enExample)
EP (1) EP2536428B1 (enExample)
JP (2) JP2013520167A (enExample)
CN (1) CN102858368B (enExample)
CA (1) CA2789945A1 (enExample)
WO (1) WO2011102900A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009076778A1 (en) 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
WO2011102900A1 (en) 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
CN103154021A (zh) * 2010-08-16 2013-06-12 威斯特解剖及生物研究所 通用甲型流感疫苗
WO2013044203A2 (en) * 2011-09-23 2013-03-28 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPTARTMENT OF HEALTH & HUMAN SERVICES Novel influenza hemagglutinin protein-based vaccines
RU2682752C2 (ru) * 2011-09-30 2019-03-21 Медикаго Инк. Повышение выхода вирусоподобных частиц в растениях
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
US20140302124A1 (en) * 2011-10-19 2014-10-09 Immunotape, Inc. Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTION
IN2014DN07152A (enExample) 2012-03-22 2015-04-24 Fraunhofer Usa Inc
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
KR102199018B1 (ko) 2013-03-28 2021-01-07 메디카고 인코포레이티드 식물에서 인플루엔자 바이러스-유사 입자 생산
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
SG11201602522VA (en) * 2013-10-02 2016-04-28 Medimmune Llc Neutralizing anti-influenza a antibodies and uses thereof
EP3054971B1 (en) 2013-10-11 2021-03-10 The United States of America, represented by the Secretary, Department of Health and Human Services Epstein-barr virus vaccines
EP3089755A1 (en) 2014-01-03 2016-11-09 Fundacion Biofisica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
CN106559986A (zh) * 2014-06-20 2017-04-05 美国政府(由卫生和人类服务部的部长所代表) 多价流感病毒样颗粒(vlp)及其作为疫苗的用途
BR112017014219A2 (en) 2014-12-31 2018-03-06 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services multivalent nanoparticle-based vaccines
CN108348593B (zh) * 2015-08-31 2022-08-16 泰克诺瓦克斯股份有限公司 基于人呼吸道合胞病毒(hrsv)病毒样颗粒(vlps)的疫苗
CN110167585B (zh) 2016-09-02 2024-03-08 美国卫生与公众服务部 稳定化的第2组流感血凝素茎区三聚体及其用途
MX2023012554A (es) 2018-12-12 2023-11-08 Cambridge Tech Llc Vacuna universal contra la gripe.
CN110272473B (zh) * 2019-07-10 2021-03-02 军事科学院军事医学研究院军事兽医研究所 甲型流感通用型病毒样颗粒及其制备方法和应用
EP3896077A1 (en) * 2020-04-16 2021-10-20 Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Influenza virus-like particles (vlps)
US20230321219A1 (en) * 2020-08-17 2023-10-12 Technovax, Inc. SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS [SARS-CoV-2]-VIRUS-LIKE PARTICLE [VLP] VACCINE: COMPOSITIONS, DELIVERY STRATEGIES, METHODS AND USES
AU2021342576A1 (en) * 2020-09-21 2023-04-06 University Of Georgia Research Foundation, Inc. PIV5-based covid-19 vaccine
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所(新疆畜牧科学院动物临床医学研究中心) 一种禽流感病毒样颗粒组装表达系统及其应用
US20250325649A1 (en) * 2021-12-31 2025-10-23 Mynvax Private Limited Polypeptide fragments, immunogenic composition against influenza virus, and implementations thereof
CN120053630B (zh) * 2025-04-28 2025-07-18 中国医学科学院医学生物学研究所 一种广谱流感疫苗的抗原表位肽组合及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376059T1 (de) * 2000-06-23 2007-11-15 Wyeth Corp Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
US8080255B2 (en) * 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
US20060051859A1 (en) * 2004-09-09 2006-03-09 Yan Fu Long acting human interferon analogs
JP2009502789A (ja) * 2005-07-19 2009-01-29 ダウ グローバル テクノロジーズ インコーポレイティド 組み換えインフルエンザワクチン
PT1937301E (pt) * 2005-10-18 2015-09-14 Novavax Inc Partículas idênticas a vírus (vlps) da gripe funcionais
WO2007130327A2 (en) * 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
WO2007130330A2 (en) * 2006-05-01 2007-11-15 Technovax, Inc. Polyvalent influenza virus-like particle (vlp) compositions
WO2008094200A2 (en) * 2006-07-27 2008-08-07 Ligocyte Pharmaceuticals, Inc Chimeric virus-like particles
WO2008061243A2 (en) * 2006-11-16 2008-05-22 Novavax, Inc. Respiratory syncytial virus-virus like particle (vlps)
US8883479B2 (en) * 2008-11-25 2014-11-11 Baxter Healthcare Sa Method for production of pH stable enveloped viruses
CA2787099A1 (en) * 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
WO2011102900A1 (en) * 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
KR102072582B1 (ko) * 2012-12-31 2020-02-03 엘지전자 주식회사 듀얼 디스플레이 방법 및 장치

Similar Documents

Publication Publication Date Title
JP2013014622A5 (enExample)
JP2017509667A5 (enExample)
MX342716B (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
JP2015525757A5 (enExample)
JP2011105738A5 (enExample)
JP2012143233A5 (enExample)
JP2014515597A5 (enExample)
JP2012107057A5 (enExample)
JP2016535100A5 (enExample)
JP2019516735A5 (enExample)
JP2015533163A5 (enExample)
JP2015501646A5 (enExample)
JP2015518492A5 (enExample)
JP2014507563A5 (enExample)
JP2016500312A5 (enExample)
JP2016540026A5 (enExample)
JP2015511646A5 (enExample)
JP2012516348A5 (enExample)
JP2014531010A5 (enExample)
JP2014529579A5 (enExample)
JP2017014205A5 (enExample)
JP2015030781A5 (enExample)
CL2013002325A1 (es) Compuestos derivados de 4-amino-2-butenamidas, inhibidores de catepsina c; composicion farmaceutica que los comprende; procedimiento de preparacion de la composicion farmaceutica; uso del compuesto en el tratamiento de enfermedad pulmonar obstructiva cronica.
WO2016020408A3 (en) Compounds for preventing ototoxicity
CN302299574S (zh) 硬盘支架